-+ 0.00%
-+ 0.00%
-+ 0.00%

This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Benzinga·10/30/2026 14:28:59
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Needham analyst Gil Blum initiated coverage on Kazia Therapeutics Limited (NASDAQ:KZIA) with a Buy rating and announced a price target of $27. Kazia Therapeutics closed at $8.72 on Thursday. See how other analysts view this stock.
  • Cantor Fitzgerald analyst Troy Jensen initiated coverage on Pasqal Holding SA (NASDAQ:PSQL) with an Overweight rating and announced a price target of $12. Pasqal Holding shares closed at $5.24 on Thursday. See how other analysts view this stock.
  • Maxim Group analyst Naz Rahman initiated coverage on Nasus Pharma Ltd. (AMEX:NSRX) with a Buy rating and announced a price target of $7. Nasus Pharma closed at $3.19 on Thursday. See how other analysts view this stock.
  • Maxim Group analyst Anthony Vendetti initiated coverage on Legacy Education Inc. (AMEX:LGCY) with a Buy rating and announced a price target of $16. Legacy Education shares closed at $10.22 on Thursday. See how other analysts view this stock.

Considering buying KZIA stock? Here’s what analysts think:

Photo via Shutterstock